Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III
Welcome,         Profile    Billing    Logout  
 2 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Weingärtner, Oliver
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Recruiting
3
12500
Europe, Canada, Japan, US, RoW
Lepodisiran Sodium, LY3819469, Placebo
Eli Lilly and Company
Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)
03/29
03/29
GIN, NCT05438069: German Inclisiran Network: Retrospective Registry of Patients Being Treated With the siRNA Inclisiran in Germany

Recruiting
N/A
500
Europe
Jena University Hospital, Universitätsklinikum Leipzig, Charite University, Berlin, Germany, Technische Universität Dresden, Deutsches Herzzentrum Muenchen, University of Rostock, Ruhr University of Bochum, Universitätsmedizin Mannheim, LMU Klinikum
Hypercholesterolemia
12/25
12/25
JaZ, NCT05587621: Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target)

Not yet recruiting
N/A
300
Europe
statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran, dietary advice
Jena University Hospital
ST Elevation Myocardial Infarction, Non-ST Elevation Myocardial Infarction, LDL-cholesterol
04/26
12/26

Download Options